简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
INNOCARE
INNOCARE (09969.HK): Phase III Trial of Fadeucravacitinib (ICP-488) for Moderate to Severe Plaque Psoriasis Meets Primary Endpoint
Tags：
INNOCARE
09969.HK
Clinical Trial
primary endpoint
2026-07-27
INNOCARE (09969.HK): TYK2 Inhibitor Soficitinib (ICP-332) Meets Primary Endpoint in Phase II for Non-Segmental Vitiligo, 24-Week F-VASI Reduced by Around 39%-41% vs Baseline
Tags：
INNOCARE
09969.HK
Clinical Trial
2026-07-16
INNOCARE(09969.HK): NDA of Orelabrutinib for ITP Accepted by NMPA
Tags：
INNOCARE
09969.HK
New Drug Marketing Application
2026-05-28
INNOCARE(09969.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 105.82 million, YoY increase of 488.93%
Tags：
INNOCARE
09969.HK
financials
2026-04-24
Featured News
ETF
Tracker Fund Of Hong Kong (02800.HK) Falls 0.38% Intraday, AUM at HK$136.117 Billion
ETF
ChinaAMC NASDAQ 100 ETF (03086.HK) Falls 0.26% Intraday, AUM at HK$1.692 Billion
ETF
Ping An of China Trust - Ping An East-West Select ETF (03477.HK) Drops 0.17% Intraday, Average Price at HK$17.728
ETF
iShares Core MSCI China Index ETF (02801.HK) Falls 0.08% Intraday at HK$24.18
ETF
Chinaamc CSI 300 Index ETF (03188.HK) Gains 0.22% Intraday, Turnover at HK$20.8121 Million
ETF
Value Gold ETF (03081.HK) Rises 0.48% Intraday, AUM at HK$4.625 Billion
ETF
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT (07588.HK) Gains 0.53% Intraday, NAV Per Unit at HK$1.510
ETF
Csop Hang Seng Index Daily (-2x) Inverse Product (07500.HK) Rises 0.84% Intraday, Turnover at HK$93.5514 Million
ETF
iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) Gains 0.87% Intraday at HK$92.400
ETF
Samsung S&P Gsci Crude Oil Er Futures Etf (03175.HK) Rises 1.26% Intraday, Average Price at HK$11.246
Scan QR Code
Download App
